Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0O0II
|
||||
| Former ID |
DIB000170
|
||||
| Drug Name |
ASC-JMZ1
|
||||
| Indication | Bladder cancer [ICD9: 188; ICD10:C67] | Investigative | [1572605] | ||
| Company |
AndroScience Corp
|
||||
| Target and Pathway | |||||
| Target(s) | Androgen receptor | Target Info | Modulator | [1572605] | |
| Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
| Coregulation of Androgen receptor activity | |||||
| Regulation of Androgen receptor activity | |||||
| Nongenotropic Androgen signaling | |||||
| Regulation of nuclear beta catenin signaling and target gene transcription | |||||
| FOXA1 transcription factor network | |||||
| Notch-mediated HES/HEY network | |||||
| References | |||||